Science Sparks @ ACTREC
27th October 2025Publications
- 1. Birwatkar S, Ghosh T, Selukar R, Lopes R, Khare NK, Raghuram GV, Shabrish S, Mittra I (2025). DsDNA breaks inflicted by cell-free chromatin particles selectively target telomeres. Scientific Reports. 15(1):36470.
- 2. Gupta S, Nair N, Hawaldar RW, Joshi S, Gulia S, Shet T, Sarin R, Parmar V, Desai S, Ghosh J, Wadasadawala T, Vanmali V, Panhale T, Parab P, Patil A, Chitkara G, Rath S, Bajpai J, Pathak R, Popat P, Thakur M, Badwe RA (2025). Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial. Journal of Clinical Oncology.
- 3. Chakrabarty N, Bhalla AS, Jana M, Mahajan A (2025). Imaging spectrum of mesenchymal tumors of lungs and pleura. Journal of Thoracic Imaging. 40(6):e0839.
- 4. Srinivasan S, Aggarwal M, Patkar N, Gurjar P, Dhamne C, Roy Moulik N, Chichra A, Chatterjee G, Rajpal S, Tembhare P, Shetty D, Subramanian P.G, Narula G, Banavali S (2025). Prevalence and Prognostic Impact of NPM1 mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in India. Clinical Lymphoma Myeloma and Leukemia. Book
1. Prakash D, Kotian RP (2025): Fundamentals of X-ray Imaging: Basic Principles, Quality Control, Clinical Applications and Safety. Springer, Singapore (ISBN: 978-981-96-7327-8)
Interesting Reads
Video of the Week
Cancer Research with MRI: Deciphering the Alphabet Soup
Upcoming Events
November 1-2, 2025
At ACTREC, Tata Memorial Centre, Kharghar
November 4, 2025
At ACTREC, Seminar Room, RRU 7th floor, Tata Memorial Centre, Kharghar
November 12-14, 2025
At ACTREC, Tata Memorial Centre, Kharghar
Do You Know?
In 1978, Researchers developed and carry out the first trial of tamoxifen to prevent recurrence in breast cancer survivors.
Cancer News
Nature, 22/10/2025
The researchers report that if mice are genetically engineered to prevent the expression of either the gene Spp1, which encodes SPP1, or the gene Itgb3, which encodes the SPP1 receptor called integrin β3 (ITGB3, also known as CD61), this prevents metastasis by blocking the formation of mesenchymal cells...
News-Medical, 21/10/2025
The new study shows how RNA-normally just a messenger-gets hijacked to build liquid-like "droplet hubs" in the nucleus. These hubs act as command centers, switching on growth-promoting genes...
Sciencedaily, 20/10/2025
Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients with Merkel cell carcinoma after surgery. Though recurrence rates overall weren’t significantly changed, the results hint at a meaningful benefit in preventing cancer spread...
© 2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)